Global Collaboration Leverage Acidophil's U.S. and U.K. footprint to source cross-border co-development opportunities in human health, agriculture and animal health. Position as a capital-efficient partner for scientists, entrepreneurs and investors to jointly create and finance new biotech assets.

Investment Partnerships Acidophil emphasizes co-financing and collaboration with investors; sales approach is to connect with corporate venture arms, family offices and grant programs to create deal-sourcing pipelines and potential structures for early-stage assets.

Vertical Market Focus With activity across human health, agriculture and animal health, pursue licensing and collaboration deals for Chalante and related platforms. Propose targeted pilots with pharma, ag biotech and animal health firms to validate and monetize early-stage assets.

Global Grants The dual US-UK presence enables access to Horizon Europe, NIH, UKRI and similar programs. Offer to support grant strategy, consortium building and regulatory pathway planning to accelerate funding and partnerships.

Digital BD Model A virtual business development approach supports scalable outreach with very small staff. Offer outsourced BD, strategic marketing, CRM and partner ecosystem services, leveraging the WordPress and PWA tech stack to boost visibility and lead generation.